Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study

Affiliations

• ¹ Clinique medicale l'Actuel, Montreal, QC, Canada.
• ² UCLA Clinical AIDS Research and Education Center, University of California, Los Angeles, CA, USA.
• ³ CascAIDS Research, Toronto, ON, Canada.
• ⁴ Central Texas Clinical Research, Austin, TX, USA.
• ⁵ Hope Clinical Research, San Juan, Puerto Rico.
• ⁶ ViiV Healthcare, Research Triangle Park, NC, USA.
• ⁷ ViiV Healthcare, Collegeville, PA, USA.
• ⁸ GlaxoSmithKline, Stockley Park, UK.
• ⁹ ViiV Healthcare, Brentford, UK.